Title : Efficiency of neonatal screening for congenital adrenal 1 hyperplasia due to 21-hydroxylase deficiency in children born in mainland 2 France between 1996 and 2003 3 Short title : Screening for congenital adrenal hyperplasia 4

Bénédicte Coulm, Joel Coste, Véronique Tardy, Emmanuel Ecosse, Michel Roussey, et al.. Efficiency of Neonatal Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency in Children Born in Mainland France Between 1996 and 2003.: Screening for congenital adrenal hyperplasia. Medicine Archives of Pediatrics & Adolescent JAMA Pediatrics , American Medical Association JAMA Network, 2012, 166 (2), pp.113-120. .

[1]  V. Sulmont,et al.  Phenotype-genotype correlations of 13 rare CYP21A2 mutations detected in 46 patients affected with 21-hydroxylase deficiency and in one carrier. , 2010, The Journal of clinical endocrinology and metabolism.

[2]  Byung-Kwang Yoo,et al.  The Cost Effectiveness of Screening Newborns for Congenital Adrenal Hyperplasia , 2008, Public Health Genomics.

[3]  J. Loeber,et al.  Neonatal screening in Europe; the situation in 2004 , 2007, Journal of Inherited Metabolic Disease.

[4]  S. Grosse,et al.  How Many Deaths Can Be Prevented by Newborn Screening for Congenital Adrenal Hyperplasia? , 2007, Hormone Research in Paediatrics.

[5]  Stef van Buuren,et al.  Reference chart for relative weight change to detect hypernatraemic dehydration , 2006, Archives of Disease in Childhood.

[6]  J. Popović,et al.  Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2005, Journal for specialists in pediatric nursing : JSPN.

[7]  M. Forest,et al.  Delayed diagnosis of congenital adrenal hyperplasia with salt wasting due to type II 3beta-hydroxysteroid dehydrogenase deficiency. , 2005, The Journal of clinical endocrinology and metabolism.

[8]  D. Chace,et al.  Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. , 2004, The Journal of clinical endocrinology and metabolism.

[9]  E. Schoenle,et al.  High reliability of neonatal screening for congenital adrenal hyperplasia in Switzerland. , 2002, The Journal of clinical endocrinology and metabolism.

[10]  C. Noordam,et al.  Newborn screening for congenital adrenal hyperplasia in the Netherlands. , 2001, Pediatrics.

[11]  A. Nordenström,et al.  Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. , 2001, Pediatrics.

[12]  G. Heinze,et al.  Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries. , 2001, The Journal of clinical endocrinology and metabolism.

[13]  H. L. Fleshood.  Newborn screening for congenital adrenal hyperplasia. , 2000, Tennessee medicine : journal of the Tennessee Medical Association.

[14]  J. Farriaux,et al.  [The wonderful history of neonatal screening]. , 2000, Annales de biologie clinique.

[15]  S. Vanderbecken,et al.  [Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980-1996]. , 1999, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[16]  S. Berenbaum,et al.  Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia , 1998, Pediatrics.

[17]  C. Cronin,et al.  Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. , 1995, The Journal of pediatrics.

[18]  G. Ellis,et al.  Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. , 1992, Clinical chemistry.

[19]  W. Miller,et al.  Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1991, Advances in human genetics.

[20]  J. Hall.  Advances in Human Genetics , 1990, Advances in Human Genetics.

[21]  K. Fujieda,et al.  Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1988, Pediatrics.

[22]  J. M. Wilson.  The evaluation of the worth of early disease detection. , 1968, The Journal of the Royal College of General Practitioners.